T39.2X2 Category · further specificity required Poisoning by pyrazolone derivatives, intentional self-harm
ICD-10-CM T39.2X2 identifies “Poisoning by pyrazolone derivatives, intentional self-harm” as a category requiring further specificity in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Chapter 19: Injury, poisoning and certain other consequences of external causes
Code-level instructions
No additional notes.
Inherited instructions
Chapters 19 · Injury, poisoning and certain other consequences of external causes (S00-T88)
Excludes 22
- birth trauma (P10-P15)
- obstetric trauma (O70-O71)
Use additional code1
code to identify any retained foreign body, if applicable (Z18.-)
Note2
- Use secondary code(s) from Chapter 20, External causes of morbidity, to indicate cause of injury. Codes within the T section that include the external cause do not require an additional external cause code
- The chapter uses the S-section for coding different types of injuries related to single body regions and the T-section to cover injuries to unspecified body regions as well as poisoning and certain other consequences of external causes.
T36-T50 · Poisoning by, adverse effects of and underdosing of drugs, medicaments and biological substances (T36-T50)
Includes4
- adverse effect of correct substance properly administered
- poisoning by overdose of substance
- poisoning by wrong substance given or taken in error
- underdosing by (inadvertently) (deliberately) taking less substance than prescribed or instructed
Excludes 11
toxic reaction to local anesthesia in pregnancy (O29.3-)
Excludes 25
Code first7
Use additional code4
Note1
The drug giving rise to the adverse effect should be identified by use of codes from categories T36-T50 with fifth or sixth character 5.
T39 · Poisoning by, adverse effect of and underdosing of nonopioid analgesics, antipyretics and antirheumatics
Seventh character1
The appropriate 7th character is to be added to each code from category T39
A — initial encounter
D — subsequent encounter
S — sequela
More specific codes
T39.2X2APoisoning by pyrazolone derivatives, intentional self-harm, initial encounterBillable / specificT39.2X2DPoisoning by pyrazolone derivatives, intentional self-harm, subsequent encounterBillable / specificT39.2X2SPoisoning by pyrazolone derivatives, intentional self-harm, sequelaBillable / specificOfficial index references
Official index references (43)
Amidopyrine (1)
- AmidopyrineDrugs and chemicals
Aminofenazone (1)
- AminofenazoneDrugs and chemicals
Aminophenazone (1)
- AminophenazoneDrugs and chemicals
Aminopyrine (1)
- AminopyrineDrugs and chemicals
Analgesic (1)
- Analgesic › pyrazoleDrugs and chemicals
Analgin (1)
- AnalginDrugs and chemicals
Antipyrine (1)
- AntipyrineDrugs and chemicals
Azapropazone (1)
- AzapropazoneDrugs and chemicals
Butazolidin (1)
- ButazolidinDrugs and chemicals
Clofezone (1)
- ClofezoneDrugs and chemicals
Coal(carbon monoxide from) (1)
- Coal(carbon monoxide from) › tar › medicinal(ointment) › analgesics NECDrugs and chemicals
Diphenylbutazone (1)
- DiphenylbutazoneDrugs and chemicals
Dipyrone (1)
- DipyroneDrugs and chemicals
Fenazone (1)
- FenazoneDrugs and chemicals
Fenylbutazone (1)
- FenylbutazoneDrugs and chemicals
Feprazone (1)
- FeprazoneDrugs and chemicals
Hydroxyphenylbutazone (1)
- HydroxyphenylbutazoneDrugs and chemicals
Indocin (1)
- IndocinDrugs and chemicals
Isopropylaminophenazone (1)
- IsopropylaminophenazoneDrugs and chemicals
Kebuzone (1)
- KebuzoneDrugs and chemicals
Ketazon (1)
- KetazonDrugs and chemicals
Metamizole sodium (1)
- Metamizole sodiumDrugs and chemicals
Methampyrone (1)
- MethampyroneDrugs and chemicals
Mofebutazone (1)
- MofebutazoneDrugs and chemicals
Monophenylbutazone (1)
- MonophenylbutazoneDrugs and chemicals
Myochrysin(e) (1)
- Myochrysin(e)Drugs and chemicals
Nifenazone (1)
- NifenazoneDrugs and chemicals
Noramidopyrine (2)
- NoramidopyrineDrugs and chemicals
- Noramidopyrine › methanesulfonate sodiumDrugs and chemicals
Oxyphenbutazone (1)
- OxyphenbutazoneDrugs and chemicals
Phenazone (1)
- PhenazoneDrugs and chemicals
Phenyl (1)
- Phenyl › butazoneDrugs and chemicals
Phenylbutazone (1)
- PhenylbutazoneDrugs and chemicals
Propyphenazone (1)
- PropyphenazoneDrugs and chemicals
Pyramidon (1)
- PyramidonDrugs and chemicals
Pyrazole(derivatives) (1)
- Pyrazole(derivatives)Drugs and chemicals
Pyrazolone analgesic NEC (1)
- Pyrazolone analgesic NECDrugs and chemicals
Ramifenazone (1)
- RamifenazoneDrugs and chemicals
Sulfamazone (1)
- SulfamazoneDrugs and chemicals
Sulfamidopyrine (1)
- SulfamidopyrineDrugs and chemicals
Sulpyrine (1)
- SulpyrineDrugs and chemicals
Suxibuzone (1)
- SuxibuzoneDrugs and chemicals
Tandearil, tanderil (1)
- Tandearil, tanderilDrugs and chemicals
History
Code history
Latest recorded change · FY2025 · 04-01
Effective from
- Inherited rules changed
Poisoning by pyrazolone derivatives, intentional self-harm
Category — select a more specific code
CDC/NCHS · FY2025 · 04-01All editions (19)
| All editions | Effective from | Code history |
|---|---|---|
| FY2016 | 2015-10-01 | First observed |
| FY2017 | 2016-10-01 | No tabular change |
| FY2018 | 2017-10-01 | No tabular change |
| FY2019 | 2018-10-01 | Inherited rules changed |
| FY2020 | 2019-10-01 | No tabular change |
| FY2020 · April | 2020-04-01 | No tabular change |
| FY2021 | 2020-10-01 | Inherited rules changed |
| FY2021 · 01-01 | 2021-01-01 | No tabular change |
| FY2022 | 2021-10-01 | No tabular change |
| FY2022 · 04-01 | 2022-04-01 | No tabular change |
| FY2023 | 2022-10-01 | No tabular change |
| FY2023 · 04-01 | 2023-04-01 | No tabular change |
| FY2024 | 2023-10-01 | No tabular change |
| FY2024 · 04-01 | 2024-04-01 | No tabular change |
| FY2025 | 2024-10-01 | No tabular change |
| FY2025 · 04-01 | 2025-04-01 | Inherited rules changed |
| FY2026 | 2025-10-01 | No tabular change |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
Explore the more specific codes in this category. Reference checks do not establish clinical appropriateness or guarantee reimbursement.